CY1111839T1 - Μεθοδος για την διαγνωση της πολλαπλης σκληρυνσης - Google Patents

Μεθοδος για την διαγνωση της πολλαπλης σκληρυνσης

Info

Publication number
CY1111839T1
CY1111839T1 CY20111100322T CY111100322T CY1111839T1 CY 1111839 T1 CY1111839 T1 CY 1111839T1 CY 20111100322 T CY20111100322 T CY 20111100322T CY 111100322 T CY111100322 T CY 111100322T CY 1111839 T1 CY1111839 T1 CY 1111839T1
Authority
CY
Cyprus
Prior art keywords
diagnosis
multiple science
science
reagent
application
Prior art date
Application number
CY20111100322T
Other languages
English (en)
Inventor
Nir Dotan
Avinoam Dukler
Mikael Scwartz
Original Assignee
Glycominds Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd. filed Critical Glycominds Ltd.
Publication of CY1111839T1 publication Critical patent/CY1111839T1/el

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/285Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Control Of Electric Motors In General (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Αποκαλύπτεται μία μέθοδος για την διάγνωση της πολλαπλής σκλήρυνσης και περισσότερο δε ειδικότερα μία μέθοδος για την διάγνωση της πολλαπλής σκλήρυνσης μέσω μέτρησης των επιπέδων αντισωμάτων έναντι γλυκανών σε ένα βιολογικό δείγμα.
CY20111100322T 2005-01-31 2011-03-24 Μεθοδος για την διαγνωση της πολλαπλης σκληρυνσης CY1111839T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/047,124 US7572592B2 (en) 2005-01-31 2005-01-31 Method for diagnosing multiple sclerosis
EP06765559A EP1856531B1 (en) 2005-01-31 2006-01-31 Method for diagnosing multiple sclerosis

Publications (1)

Publication Number Publication Date
CY1111839T1 true CY1111839T1 (el) 2015-10-07

Family

ID=36757039

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100322T CY1111839T1 (el) 2005-01-31 2011-03-24 Μεθοδος για την διαγνωση της πολλαπλης σκληρυνσης

Country Status (15)

Country Link
US (4) US7572592B2 (el)
EP (1) EP1856531B1 (el)
AT (1) ATE493656T1 (el)
AU (1) AU2006242939B2 (el)
CA (1) CA2595277A1 (el)
CY (1) CY1111839T1 (el)
DE (1) DE602006019206D1 (el)
DK (1) DK1856531T3 (el)
ES (1) ES2358606T3 (el)
IL (1) IL184905A (el)
NZ (1) NZ560978A (el)
PL (1) PL1856531T3 (el)
PT (1) PT1856531E (el)
SI (1) SI1856531T1 (el)
WO (1) WO2006117689A2 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210512B1 (pl) * 2002-08-02 2012-01-31 Glycominds Ltd Sposób, zestaw i podłoże do diagnozowania stwardnienia rozsianego
US8216791B2 (en) * 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
EP2074424A2 (en) * 2006-08-29 2009-07-01 Glycominds Ltd. Method of diagnosing and stratifying anti-phospholipid syndrome
CN101978269A (zh) 2008-01-18 2011-02-16 哈佛大学校长及研究员协会 在体液中检测疾病或病症标志的方法
CN102388307B (zh) 2008-11-12 2014-09-03 耶达研究与发展有限公司 多发性硬化的诊断
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
US20120190581A1 (en) * 2009-08-25 2012-07-26 The Johns Hopkins University Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases
US20120053073A1 (en) 2010-07-23 2012-03-01 President And Fellows Of Harvard College Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids
US20130184178A1 (en) 2010-07-23 2013-07-18 President And Fellows Of Harvard College Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions
US20120040846A1 (en) 2010-07-23 2012-02-16 President And Fellows Of Harvard College Methods of Detecting Diseases or Conditions Using Phagocytic Cells
EP2596353A4 (en) 2010-07-23 2014-01-15 Harvard College METHOD FOR DETECTING PRENATAL OR PREGNANT DISEASES OR SUFFERING
KR20150035818A (ko) 2012-06-15 2015-04-07 해리 스타일리 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ, 疾患または状態を検出する方法
EP4202441A3 (en) 2013-03-09 2023-07-26 Immunis.AI, Inc. Gene expression profile in macrophages for the diagnosis of cancer
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
US9927437B2 (en) 2013-12-12 2018-03-27 The Brigham And Women's Hospital, Inc. Treating neurodegenerative disease
AU2015314813B2 (en) 2014-09-11 2022-02-24 Immunis.Ai, Inc. Methods of detecting prostate cancer
WO2016123565A1 (en) 2015-01-30 2016-08-04 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of ms disease course
US10538794B2 (en) 2016-11-29 2020-01-21 Emory University Oligosaccharide libraries and methods of production
EP3401682A1 (en) * 2017-05-09 2018-11-14 Université de Nantes Diagnosis, prevention and treatment of demyelinating disorders of the central nervous system
WO2021158845A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158843A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158838A1 (en) 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Dosage regimen of an s1p receptor modulator
WO2021158841A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158844A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158839A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158847A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030560A (en) 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
EA200100896A1 (ru) 1999-02-17 2002-04-25 Гликоминдс Лтд. Комбинаторные библиотеки сложных углеводов и способы их получения и использования
US6994966B2 (en) 2000-02-17 2006-02-07 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
KR20020089323A (ko) 2000-01-10 2002-11-29 제노스펙트라 인코포레이티드 선형 프로브 캐리어
WO2002018950A1 (en) 2000-08-28 2002-03-07 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20040241763A1 (en) 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
PL210512B1 (pl) 2002-08-02 2012-01-31 Glycominds Ltd Sposób, zestaw i podłoże do diagnozowania stwardnienia rozsianego
AU2003282612A1 (en) 2002-10-11 2004-05-04 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
DE602006019206D1 (de) 2011-02-10
WO2006117689A3 (en) 2007-01-25
SI1856531T1 (sl) 2011-05-31
US8129128B2 (en) 2012-03-06
US7572592B2 (en) 2009-08-11
PL1856531T3 (pl) 2011-07-29
IL184905A (en) 2012-02-29
PT1856531E (pt) 2011-03-24
AU2006242939B2 (en) 2012-04-19
CA2595277A1 (en) 2006-11-09
ATE493656T1 (de) 2011-01-15
US7906291B2 (en) 2011-03-15
DK1856531T3 (da) 2011-04-18
ES2358606T3 (es) 2011-05-12
US20110092383A1 (en) 2011-04-21
US20060172338A1 (en) 2006-08-03
AU2006242939A1 (en) 2006-11-09
US20090291456A1 (en) 2009-11-26
EP1856531B1 (en) 2010-12-29
NZ560978A (en) 2010-12-24
US20060234301A1 (en) 2006-10-19
WO2006117689A2 (en) 2006-11-09
IL184905A0 (en) 2007-12-03
EP1856531A2 (en) 2007-11-21

Similar Documents

Publication Publication Date Title
CY1111839T1 (el) Μεθοδος για την διαγνωση της πολλαπλης σκληρυνσης
ATE507720T1 (de) Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands
EA201100231A1 (ru) Диагностический анализ на основе антител
EA200802272A1 (ru) Новые маркеры для пренатальной диагностики и мониторинга
DE602006008829D1 (de) Kolbenring für verbrennungsmotoren
DE502007004793D1 (de) Ventilanordnung für eine abgasrückführeinrichtung
DE50208549D1 (de) Wellendichtung für Turbolader
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
RU2417590C3 (ru) Фунгицидная композиция
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
DE602006013447D1 (de) Uerverfahren für leistungsabgabevorrichtung
DE602006010956D1 (de) Magnetische Partikel für die Diagnostik
CY2013046I2 (el) Καινοτομος χρηση των αντισωματων αντι il-1bhta
AR075498A1 (es) Metodos para la preparacion de arilamidas
EA201000257A1 (ru) Новый способ синтеза (7-метокси-l-нафтил) ацетонитрила и применение в синтезе агомелатина
DK1858929T3 (da) DIAGNOSE af PROSTATACANCER
DE502005005946D1 (de) Flanschverbindung für Leitungen
EA200801884A1 (ru) Новый способ синтеза ранелата стронция и его гидратов
BRPI0811290A2 (pt) Eliminação de interferência em imunoensaios causada por anticorpos anticarboidrato
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
ATE486199T1 (de) Dekompressionsbremsvorrichtung für brennkraftmaschinen
DE602006017336D1 (de) Prozessverbindung für prozessdiagnostik
EA200801476A1 (ru) Замещенные аминофенилсульфонамидные соединения в качестве ингибиторов протеазы вич
ATE479100T1 (de) Verfahren zur diagnose von lawsonia intracellularis
DE602006018458D1 (de) Antikörper gegen histonmodifikationen für die klinische krebsdiagnose und -prognose